articleJournal of Clinical OncologyOct 21, 2003Closed access

The Effect on Tumor Response of Adding Sequential Preoperative Docetaxel to Preoperative Doxorubicin and Cyclophosphamide: Preliminary Results From National Surgical Adjuvant Breast and Bowel Project Protocol B-27

NSABP Foundation

PubMed
Indexed incrossrefpubmed

Abstract

PURPOSE: The National Surgical Adjuvant Breast and Bowel Project Protocol B-27 was designed to determine the effect of adding docetaxel after four cycles of preoperative doxorubicin and cyclophosphamide (AC) on clinical and pathological response rates and on disease-free and overall survival of women with operable breast cancer. PATIENTS AND METHODS: Women (N = 2,411) with operable primary breast cancer were randomly assigned to receive either four cycles of preoperative AC followed by surgery (group I), or four cycles of AC followed by four cycles of docetaxel, followed by surgery (group II), or four cycles of AC followed by surgery and then four cycles of docetaxel (group III). Clinical and pathologic tumor…

Citation impact

1,131
total citations
FWCI
28.73
Percentile
100%
References
70
Citations per year

Authors

11

Topics & keywords

Keywords
  • Medicine
  • Docetaxel
  • Cyclophosphamide
  • Breast cancer
  • Internal medicine
  • Surgery
  • Stage (stratigraphy)
  • Oncology
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.